- Research Resources
- Conferences & Seminars
- MD Anderson at ASTRO
- ASTRO Program
MD Anderson has numerous presentations throughout the ASTRO program. Note: All times are listed in Pacific Time.
MD Anderson has numerous presentations throughout the ASTRO program. Note: All times are listed in Pacific Time.
Saturday, September 27
ARRO 02 - ARRO Annual Resident Seminar (ARRO Day)
11:00 a.m.–5:15 p.m.
Room 156/158
Jobs Panel: Career Opportunities and Leadership Outside of the Clinic
Moderator: Rehema Thomas, M.D.
ARRO 03 - ASTRO-ARRO Medical Student Workshop
12:00–4:00 p.m.
Room 154
Panel: Shaping Your Path: Academic & Extracurricular Excellence in RadOnc
Panel Speaker: Stephanie Dudzinski, M.D., Ph.D.
PRO 07 - Indolent Lymphomas: Radiation Oncology Considerations
3:45–5:00 p.m.
Room 301-304
Talk: Toxicity Reduction Efforts with Radiation Therapy
Presenter: Chelsea Pinnix, M.D., Ph.D.
Sunday, September 28
SH 12 - Sarcoma and Cutaneous Tumors - Science Highlights
8:00–8:30 a.m.
Room 305/306/309
Discussant: Andrew Bishop, M.D.
ASPP 01 - 2025 Aspiring Scientists and Physicians Program
11:00–3:00 p.m.
Room 154
Career Pathways Panelist: Julianne Pollard-Larkin, Ph.D.
SS 04 - GYN 1: Molecular and Precision Medicine for Gynecologic Cancers in Diverse Resource Settings
2:30–3:45 p.m.
Room 160
Discussant: Ann Klopp, M.D., Ph.D.
4:45–6:00 p.m.
Room 20/21
Talk: Setting Up a Global Oncology Program: Identifying International Partners
Presenter: Kathleen Schmeler, M.D.
SS 09 - Head and Neck 1: Highest-Rated Abstracts for Virally-Mediated Head and Neck Cancer
4:45–6:00 p.m.
Room 305/306/309
Moderator: Anna Lee, M.D.
SS 10 - Patient Reported Outcomes/QoL/Survivorship 1: Fixing What's Broken and Reaching for the Sky
4:45–6:00 p.m.
Room 314
Moderator: Aileen Chen, M.D.
Abstract 161: Evaluating the Relationship of Baseline Skin Pigmentation Phenotype on the Evolution of Radiation Dermatitis
Presenter: Alison Yoder, M.D.
EDU 08 - Radiotherapy for Leukemia: Past, Present and Future
4:45–6:00 p.m.
Room 160
Talk: Indications for Radiation Therapy in Leukemia: A Shifting Landscape
Presenter: Susan Wu, M.D.
4:45–6:00 p.m.
Room 153
Abstract 172: The Role of Adjuvant Primary Site Radiotherapy for Patients with Cutaneous Melanoma Microsatellitosis
Presenter: Kelsey Nordlund
Abstract 173: A Prospective Single-Arm Trial of Postoperative 36 Gy in 10 Fractions for Merkel Cell Carcinoma
Presenter: Devarati Mitra, M.D., Ph.D.
Abstract 175: Surgical Graft and Flap Toxicity Following Hypofractionated Adjuvant Radiotherapy for Primary Cutaneous Melanoma
Presenter: Noel Yang
Monday, September 29
SS 13 - DHI 1: The Digital Revolution in Radiation Oncology: AI Models for Enhanced Patient Care
8:00–9:00 a.m.
Room 20/21
Abstract 178: Crowdsourcing Tumor Auto-Contouring Solutions for MR-Guided Radiotherapy: The HNTS-MRG 2024 Challenge
Presenter: Kareem Wahid, Ph.D.
8:00–9:00 a.m.
Room 160
Moderator: Molly Tate, Ph.D.
10:45 a.m.–12:00 p.m.
Room 307/308
Moderator and Introduction: Debra Yeboa, M.D.
Talk: Target Volumes and Techniques for Definitive EBRT
Presenter: Mary Frances McAleer, M.D., Ph.D.
SS 17 - Hem 1: Bridging the Gap: Radiotherapy Innovations in Aggressive Lymphomas
10:45 a.m.–12:00 p.m.
Room 152
Moderator: Penny Fang, M.D.
SS 22 - Radiation and Cancer Physics 2: Imaging Biomarkers for Response Monitoring
10:45 a.m.–12:00 p.m.
Room 22/23
Abstract 233: Early Prediction of Radiotherapy Outcome Using ADC Metrics for Head & Neck Squamous Cell Carcinoma
Presenter: Brigid McDonald, Ph.D.
Abstract 235: Unveiling Early Radiation Effects on the Hippocampus: ADC Dynamics Reveal Microstructural Changes during Therapy
Presenter: Ory Haisraely, M.D.
ST 01 - Radiotherapy in Conflict Zones: Stories of Struggles, Resilience and Hope
10:45 a.m.–12:00 p.m.
Room 314
Speaker: Yasir Elamin, M.D.
3:00–4:00 p.m.
ASTRO Communities Lounge
Speaker: Wendy Woodward, M.D., Ph.D.
SS 23 - GU 5: Milestones in Metastatic Prostate Cancer
3:00–4:00 p.m.
Room 156/158
Discussant: Comron Hassanzadeh, M.D.
SS 26 - Radiation and Cancer Physics 3: Imaging Development for Planning
3:00–4:00 p.m.
Room 155/157
Abstract 255: Changes in High-Grade Glioma Target Volume and Prescription Dose Coverage between Postoperative MRI and MR-Simulation
Presenter: Sara Thower, Ph.D.
Exhibit Hall Networking Reception
4:00–5:00
Booth 2137
5:00–6:00 p.m.
Room 160
Talk: Radiation Therapy for Grade 2-3 IDH-mutant Gliomas: Evidence, Innovation, and Evolving Practices
Presenter: Martin Tom, M.D.
5:00–6:00 p.m.
Room 156/158
Moderator: Chelain Goodman, M.D., Ph.D.
EDU 31 - Focused Update of ASTRO Rectal Cancer Guidelines: Case-Based Discussion
5:00–6:00 p.m.
Room 159
Moderator: Prajnan Das, M.D.
SS 28 - GU 6: Revelations in Renal Radiotherapy
5:00–6:00 p.m.
Room 301-304
Discussant: Chad Tang, M.D.
5:00–6:00 p.m.
Room 307/308
Moderator: Anuja Jhingran, M.D.
SS 29 - Lung 3: NSCLC Early Stage and SBRT
5:00–6:00 p.m.
Room 155/157
Abstract 268: Ten-Year Outcomes of the Revised STARS Trial Comparing Radiation and Surgery for Early-Stage Non-Small Cell Lung Cancer
Presenter: Troy Kleber, M.D.
Discussant: Joe Chang M.D., Ph.D.
ST 02 - Radiation Care and Survivorship in the Adolescent and Young Adult Cancer Population
5:00–6:00 p.m.
Room 20/21
Moderator, Questions and Answers: Fumiko Chino, M.D.
Talk: Addressing the Gaps: Rising Cancer Rates, Disparities, and Unique Needs in AYA Patients with Cancer
Presenter: Kelsey Corrigan, M.D.
Tuesday, September 30
8:00–9:00 a.m.
Room 156/158
Discussant: Ethan Ludmir, M.D.
QP 07 - GYN 3: Quick Pitch: Molecular Predictors of Outcomes in Cervical Cancer
8:00–9:00 a.m.
Room 159
Moderator: Lilie Lin, M.D.
8:00–9:00 a.m.
Room 154
Speaker: Phuoc Tran, M.D., Ph.D.
SS 35 - CNS 3: Spine, Benign, and FLASH: Oh My!
12:45–2:00 p.m.
Room 310-312
Abstract 304: Genomic Mutation-Driven Stratification of Treatment Response to Stereotactic Spine Radiosurgery in Spinal Metastases
Presenter: Areeba Al-Sharfeen
12:45–2:00 p.m.
Room 20/21
Abstract 1056: Vision-Language AI Model for Detecting PET/CT-Occult Lymph Node Metastasis in Early-Stage NSCLC Treated with SABR to Prevent Regional Recurrence
Presenter: Hui Xu, Ph.D.
EDU 41 - Riding the Waves of New Small Cell Lung Cancer Therapeutics
12:45–2:00 p.m.
Room 155/157
Talk: Is There Still a Role for Radiotherapy in Extensive Stage SCLC?
Presenter: Quynh-Nhu Nguyen, M.D.
EDU 42 - The Role of Radiotherapy in Modern Treatment of Endometrial Cancer - The Great Debate
12:45–2:00 p.m.
Room 159
Talk: The Role of Radiotherapy in Modern Treatment of Endometrial Cancer - the Great Debate
Presenter: Ann Klopp, M.D., Ph.D.
LBA 01 - Late Breaking Abstracts
2:30–3:45 p.m.
Room 22/23
Abstract LBA 11: Addition of Metastasis-Directed Therapy to Standard of Care: Primary Aggregate Analysis and Immunologic Correlatives of the Phase II Randomized EXTEND Trial
Presenter: Alexander Sherry, M.D.
2:30–4:00 p.m.
Room 154
Case Discussions: Chad Tang, M.D.
Workshop 04 - Grant Writing Workshop
2:30–4:30 p.m.
Room 153
The New NIH Review Criteria and Introductions
Moderator and Presenter: Debra Yeboa, M.D.
Specific Aims
Presenter: Kristy Brock, Ph.D.
EDU 46 - Raising the Floor of Oncology Care in the US: Reimagining the Role of Radiation Oncologists
2:30–3:45 p.m.
Room 159
Introductions, Questions and Answers: Albert Koong, M.D., Ph.D.
SS 43 - Lung 5: Locally Advanced NSCLC: PORT and Cardiac Toxicity
4:00–5:00 p.m.
Room 155/157
Moderator: Stephen Chun, M.D.
EDU 52 - To Radiate or Not Radiate? Updates to Management of Retroperitoneal Sarcoma
4:00–5:00 p.m.
Room 160
Talk: Surgical Considerations and Challenges for the Management of Patients with Retroperitoneal Sarcoma
Presenter: Emily Keung, M.D.
EDU 55 - The Bioethics of Radiation Oncology: Challenging Clinical Cases
5:15–6:15 p.m.
Room 159
Talk: Informed Consent in the Context of Non-disclosure of Cancer Diagnosis
Presenter: Subha Perni, M.D.
QP 16 - Head and Neck 5: Quick Pitch: From Fraction to Function: Tailoring Head & Neck Radiotherapy
5:15–6:15 p.m.
Room 151
Abstract 1093: A Double-Blinded Analysis of Radiation Dermatitis in Patients with Advanced Oropharyngeal Cancer Treated with IMPT vs. IMRT
Presenter: Steven Frank, M.D.
Wednesday, October 1
8:00–9:00 a.m.
Room 154
Abstract 1113: Endoscopic Ultrasound Fine Needle Injection of NBTXR3 Activated by Radiotherapy with Concurrent Chemotherapy for Adenocarcinoma of the Esophagus: Feasibility and Safety of the Phase I Dose Escalation Part for the Photon-Based Cohort
Presenter: Steven Lin, M.D., Ph.D.
SS 44 - Radiation and Cancer Physics 8: Workflow and On-board Imaging
8:00–9:00 a.m.
Room 152
Abstract 355: Toward Advancement of Pediatric Cancer Treatment: A Comparative Study of Pediatric-Specific Models and Adult-Trained Commercial Tools for Radiotherapy Auto-Contouring
Presenter: Sogand Sadeghi, Ph.D.
QP 22 - Radiation and Cancer Physics 9: Motion Management
8:00–9:00 a.m.
Room 160
Abstract 1129: Longitudinal Analysis of Log Files from Gated Delivery of Stereotactic Body Radiotherapy Using Motion Management in a 1.5 T MR-Linac
Presenter: Lucas McCullum
QP 24 - Radiation and Cancer Biology 7: Tumor Immune Interactions
10:30–11:30 a.m.
Room 159
Abstract 1143: Quantifying pan-cancer immune temperature to predict patient-specific radiation response and outcome
Presenter: Awino Maureiq Ojwang', Ph.D.
SS 46 - Radiation and Cancer Physics 10: Functional and Quantitative Imaging Method Development
10:30–11:45 a.m.
Room 152
Abstract 365: Simultaneous T1, T2, T2*, and PDFF Estimation Using Magnetic Resonance Fingerprinting on a 1.5T MR-Linac for Head and Neck Cancer Patients
Presenter: Lucas McCullum
SS 45 - GU 10: Biomarker Breakthroughs in Prostate Cancer
10:30–11:45 a.m.
Room 154
Abstract 358: Validation of Six Androgen Production, Uptake and Conversion Genes (APUC-6) in the ECOG-ACRIN E3805 CHAARTED Prostate Cancer Trial
Presenter: Phuoc Tran, M.D., Ph.D.
Posters
Sunday
PQA 01 - Radiation and Cancer Physics, Sarcoma and Cutaneous Tumors
2:30–4:00 p.m.
Hall F
Abstract 2118: Outcomes for Patients with Localized Intrathoracic Soft Tissue Sarcomas Treated with Surgery and Radiation Therapy
Presenter: Tejaswi Kanala, M.D., M.B.B.S.
Abstract 2122: Impact of Abdominal Compression in MR-Guided Online Adaptive Planning for Abdominal Cancers Treated with a 1.5 Tesla MR-Linac
Presenter: Moghadaseh Khaleghibizaki
Abstract 2236: Automated Analysis of Log Files from Gated Delivery of Stereotactic Body Radiotherapy Using Motion Management in a 1.5 T MR-Linac: A Multi Institution Report
Presenter: Ergys Subashi, Ph.D.
4:45–6:00 p.m.
Hall F
Abstract 2331: Outcomes of Patients with Intracranial Germinoma Enrolled on the Pediatric Proton Photon Consortium Registry
Presenter: Elaine Cha, M.D.
Abstract 2375: Proton Therapy in Pediatric Craniopharyngioma: Comparison between Adjuvant and Salvage Radiotherapy Efficacy and Toxicity
Presenter: Ory Haisraely, M.D.
Abstract 2400: Practice Variations and Outcomes of Definitive Radiation for Non-Metastatic NSCLC following Induction Chemoimmunotherapy
Presenter: Troy Kleber, M.D.
Abstract 2431: Sociodemographic and Molecular Determinants of Disparities in NSCLC Outcomes: A Multi-Institutional Genomic Analysis
Presenter: Cesar Marquez, M.D., Ph.D.
Abstract 2442: Charlson Comorbidity Index as a Predictive Tool of Treatment Tolerance and Outcomes in Elderly Non-Small Cell Lung Cancer Patients Treated with Concurrent Proton or Photon Chemoradiation Followed by Immunotherapy
Presenter: Cira Mollings Puentes, M.D.
Abstract 2446: Association between Geotemporal PM2.5 and Outcomes in Unresectable NSCLC Treated with Chemoradiotherapy
Presenter: Ansel Nalin, M.D., Ph.D.
Monday
PQA 03 - Central Nervous System, Professional Development/Medical Education
8:00–9:00 a.m.
Hall F
Abstract 2573: Long-Term Outcomes in IDH-Wildtype Gliomas with Historical WHO Grade 2 and 3 Histology
Presenter: Patrick Carriere, M.D., Ph.D.
Abstract 2623: Salvage Fractionated Stereotactic Spine Radiosurgery for Recurrent Metastatic Renal Cell Carcinoma
Presenter: Forrest Kwong, M.D.
Abstract 2651: Outcomes for Patients with High-Risk IDH-Mutant Grade 2 Gliomas Treated with IDH Inhibitors
Presenter: Jane Pearce, M.D.
Abstract 2677: Brain Metastases from Soft Tissue Sarcoma
Presenter: Srivatsa Vedala
PQA 04 - Gynecological Cancer, Head and Neck Cancer
10:45 a.m.–12:00 p.m.
Hall F
Abstract 2728: Factors Influencing Post-Operative Pain in Gynecologic Cancer Patients Receiving High Dose Rate Brachytherapy: An ERAS Risk Factor Analysis
Presenter: Darien Colson-Fearon, M.D.
Abstract 2744: A Double-Blinded Analysis of Anterior Oral Mucositis in Patients with Advanced Oropharyngeal Cancer Treated with IMPT vs. IMRT
Presenter: Steven Frank, M.D.
Abstract 2745: Severe Sleep-Related Symptoms at Start of Radiotherapy Predict Poorer Survival in Oropharyngeal Cancer: Results from a Longitudinal Symptom Cohort
Presenter: Warren Floyd, M.D., Ph.D.
Abstract 2752: Homologous Recombination Deficiency: Is It Relevant in Locally Advanced Cervical Cancer?
Presenter: Jhoan Sebastian Gonzalez Diaz, M.D.
Abstract 2757: Outcomes of Patients with Gastric-Type Adenocarcinoma of the Uterine Cervix after Definitive or Adjuvant Chemoradiotherapy
Presenter: Harshath Gupta, M.D.
Abstract 2803: A Single Patient-Reported Outcome Item Successfully Detects Imaging-Graded Subclinical Swallow Dysfunction in Patients with Head and Neck Cancer Receiving Radiotherapy
Presenter: Beatrice Manduchi, Ph.D.
Abstract 2810: Management of De-Novo Stage IVB Cervical Cancer with Induction Chemotherapy Followed By Definitive Chemoradiation
Presenter: Cira Mollings Puentes, M.D.
PQA 05 - Breast Cancer, Health Services Research, International/Global Oncology
3:00–4:00 p.m.
Hall F
Abstract 2964: Cancer Research Training for Oncology Trainees in Zambia: Results from a Hybrid Program's In-Person Workshop
Presenter: Kamaria Lee, M.D.
Abstract 2932: Spatial Protein Profiling of irradiated breast cancer involved lymph nodes suggests nodal irradiation modulates immune function
Presenter: Stephanie Dudzinski, M.D., PhD.
Abstract 2935: To Boost or Not to Boost: Local Control in HER-2 Positive Breast Cancer after Neoadjuvant Therapy
Presenter: Mohamad El-Jammal, M.D.
PQA 06 - Radiation and Cancer Biology, Health Care Access and Engagement
5:00–6:00 p.m.
Hall F
Abstract 3051: Systemic immune activation by SARS-CoV-2 mRNA vaccines sensitizes tumors to immune checkpoint blockade
Presenter: Adam Grippin, M.D., Ph.D.
Abstract 3067: Combining High-Dose Radiation with Dual CCR8 and PD-1 Blockade to Overcome Tumor Immune Suppression
Presenter: Yun Hu, Ph.D.
Abstract 3086: Geographic Distribution of Radiation Oncology Workforce in Underserved Regions: A Cross-Specialty Analysis
Presenter: Forrest Kwong, M.D.
Abstract 3089: Health-Related Social Risks (HRSR) and Psychosocial Needs Among Patients with Breast Cancer Treated with Radiation
Presenter: Kamaria Lee, M.D.
Abstract 3109: The Impact of LET and the Tumor Immune Microenvironment on Differential Response of Genetically Engineered Pancreatic Cancer Models to Carbon Ion Radiotherapy
Presenter: Henry Meyer
Abstract 3116: High Environmental L-Lactate Facilitates DNA Damage Repair Pathway by Inducing Lactylation in Cervical Carcinoma Cells
Presenter: Dalissa Negrón-Figueroa
Tuesday
PQA 07 - Genitourinary Cancer, Patient Safety, Nursing/Supportive Care
12:45–2:00 p.m.
Hall F
Abstract 3185: Using Deep Learning to Delineate the Elective Pelvic Nodal Volumes in Patients with Prostate Cancer: A Tool Aimed to Facilitate Peer Review
Presenter: Brian Anderson, Ph.D.
Abstract 3186: Clinical Outcomes of Salvage Nodal Radiotherapy for Prostate Cancer with Prior Radiotherapy
Presenter: Maheen Ansari
Abstract 3203: CONSOLIDATE: Concurrent Radiotherapy with Enfortumab vedotin (EV) for Locally Advanced Bladder Cancer
Presenter: Patrick Carriere, M.D., Ph.D.
Abstract 3216: Safety and Early Outcomes of External Beam Radiation Therapy with Low Dose Brachytherapy Boost in Patients with Prostate Cancer
Presenter: Zakaria El Kouzi, M.D.
Abstract 3217: Assessment of Non-Randomized Comparisons of Radical Prostatectomy vs. Radiation Therapy for Prostate Cancer
Presenter: Zakaria El Kouzi, M.D.
Abstract 3243: Changing Landscapes of Adjuvant Radiotherapy after Prostatectomy in Prostate Cancer
Presenter: Harshath Gupta, M.D.
Abstract 3246: Randomized PROSTATE-IQ Trial to Reduce ADT Treatment Burden for Patients with Biochemical Recurrence after Prostatectomy
Presenter: Karen Hoffman, M.D.
Abstract 3372: Investigating Effects of Film Digitization Methods on IROC SRS Head Phantom Credentialing Results
Presenter: Michael Yang
Abstract 3297: Outcomes of Stage IIA and Stage IIB Seminoma Treated with Definitive Radiation Therapy
Presenter: Ansel Nalin, M.D., Ph.D.
Abstract 3298: Cardiovascular Disease and Diagnosis of Advanced Prostate Cancer
Presenter: Kevin Nead, M.D.
Abstract 3314: Urinary Toxicity after External Beam Radiation Therapy for Prostate Cancer following Transurethral Resection of Prostate or Laser Enucleation
Presenter: Pranalee Patel, M.D.
Abstract 3340: Treatment Outcomes of Radiation Therapy with Androgen Deprivation Therapy in Patients with N1 Prostate Cancer
Presenter: Kayeong Shin, M.D.
PQA 08 - Gastrointestinal Cancer, Nonmalignant Disease, Palliative Care
2:30–3:45 p.m.
Hall F
Abstract 3410: Modest Dose Escalation for Early-Stage Anal Cancer: Cancer Control and Toxicity Outcomes
Presenter: Sage Copling
Abstract 3510: Palliative Radiotherapy within the Last 30 Days of Life: A Multi-Site Review of Practice Patterns
Presenter: Van Handke
Abstract 3392: Phase II Trial of Autologous Lymphocyte Infusions after Radiotherapy to Mitigate Radiation Induced Lymphopenia and Enhance Immune Reconstitution in Patients with Solid Tumor Malignancies
Presenter: Enoch Chang, M.D.
4:00–5:00 p.m.
Hall F
Abstract 3591: AI Language Model Performance in Retrieving Phase III Radiotherapy Trials across Mulple Cancers
Presenter: Glennon Carevic
Abstract 3602: Outcomes for Patients with Primary Thyroid Lymphoma Treated with Radiation Therapy
Presenter: Ethan Damron, M.D.
Abstract 3623: Development of the Ontology for Osteoradionecrosis of the Jaws (ORNJ-O) for Classification System Harmonization
Presenter: Anthony Giovi
Abstract 3679: Automated Toxicity Extraction from Radiation Therapy Notes Using Large Language Models
Presenter: Jordan McDonald, M.D.
Abstract 3688: A Robust Radiotherapy Continuity System that Enables Patient Treatments during a Cybersecurity Event
Presenter: Christopher Nelson, Ph.D.
Abstract 3717: Publication Disparity in Hematologic Radiation Oncology
Presenter: Mohamad El-Jammal, M.D.
Give Now
Your gift will help make a tremendous difference.
Research Areas
Find out about the four types of research taking place at MD Anderson.
Subscribe
Get the latest information on our cancer breakthroughs.